Log in to search using one of your social media accounts:


Correspondence 23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia

Motoi Suzuki and colleagues1 found that 23-valent pneumococcal polysaccharide vaccine (PPV23) showed low to moderate effectiveness against vaccine serotype pneumococcal pneumonia in Japanese people aged 65 years or older treated at four community-based hospitals from September, 2011, to August, 2014. As the authors wrote, 7-valent pneumococcal conjugate vaccine (PCV7) became commercially available for Japanese children in February, 2010, and it was incorporated into the routine immunisation schedule for children in April, 2013.
Source: The Lancet Infectious Diseases - Category: Infectious Diseases Authors: Tags: Correspondence Source Type: research

Related Links:

More News: Children | Hospitals | Infectious Diseases | Meningitis Vaccine | Pneomococcal Vaccine | Pneumonia | Vaccines